Home > Insider Trading > Filing (0001610717-24-000456)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1885522	Neumora Therapeutics Inc.	NMRA	Biological Products, (No Disgnostic Substances) (2836)	844367680

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1992595	Joshua Pinto	C/O Neumora Therapeutics, Inc. 490 Arsenal Way, Suite 200 Watertown MA 02472	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-08-22	28,496	$11.63	210,469	No	4	S	Indirect	See footnote
Common Stock	Disposition	2024-08-23	24,169	$11.59	186,300	No	4	S	Indirect	See footnote
Common Stock	Disposition	2024-08-26	31,642	$11.78	154,658	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	85,000	Direct

Footnotes

The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on April 18, 2024 and subsequently amended on May 22, 2024.
This transaction was executed in multiple trades at prices ranging from $11.43 to $12.06, inclusive. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares held by Maple DE Holdings LLC.
This transaction was executed in multiple trades at prices ranging from $11.40 to $11.74, inclusive. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $11.61 to $11.98, inclusive. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.